Safety and efficacy of nivolumab as a second line therapy in metastatic renal cell carcinoma: a retrospective chart review

AIM: To assess diseases outcomes and tolerability of real-life second-line nivolumab in a series of metastatic renal cell carcinoma (mRCC) patients. METHODS: This retrospective chart review involved prospectively monitored patients (named patient program) treated with second-line nivolumab for mRCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamulin, Marija, Nham, Eric, Rkman, Deni, Antunac, Zrna, Golubić, Likić, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2020
Materias:
Resaerch Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480755/
https://www.ncbi.nlm.nih.gov/pubmed/32881430
http://dx.doi.org/10.3325/cmj.2020.61.326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480755/
https://www.ncbi.nlm.nih.gov/pubmed/32881430
http://dx.doi.org/10.3325/cmj.2020.61.326

Ejemplares similares